The cytotoxic environment around EBV+ HRS cells could not be effective to control EBV driven malignancy, perhaps as a consequence of IL10 presence in EBV-associated HL, which turns into the coexistence of a cytotoxic with an immune regulatory milieu. Here, IL10 is linked to Hodgkins lymphoma.